Global Substance Abuse Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

September 2018 | 118 pages | ID: GD02C44BA21EN
GlobalInfoResearch

Abstracts

Substance abuse has become a major cause of concern. People are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a high economic burden on the nation. 

Scope of the Report:

This report studies the Substance Abuse Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Substance Abuse Treatment market by product type and applications/end industries.

The rise in government initiatives for improved awareness is identified as one of the primary growth factors for this market. Various programs and initiatives have been set up by government agencies and many organisations to increase awareness about the chronic ill-effects of substance abuse. These include initiatives taken up at work places, community programs, and technical assistance programs at local, state, and national levels. The Substance Abuse and Mental Health Services Administration (SAMHSA), a branch of the U.S Department of Health and Human Services has multiple programs to improve awareness. SAMHSA's Division of Workplace Programs (DWP) supervises programs to eradicate illicit drug use in federal workplaces and helps all workplaces become drug-free. Under this program, DWP regulates various policies for a drug-free workplace.

The Americas is expected to be the major revenue contributor to the market throughout the forecast period. The rise in number of people with addiction and the rise in the number of rehabilitation centers will be the major factors propeling the growth of the substance abuse treatment market in this region.

The global Substance Abuse Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Substance Abuse Treatment.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.



Market Segment by Companies, this report covers

• Alkermes
• Allergan
• GSK
• Pfizer
• Accord Healthcare
• Amphastar Pharmaceuticals
• Apotex
• BioCorRx
• Cipla
• Glenmark

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)Market Segment by Type, covers

• Alcohol Abuse Treatment
• Nicotine Abuse Treatment
• Drug Abuse Treatment

Market Segment by Applications, can be divided into

• Hospitals
• Clinics
• Others
  
  

Contents

1 SUBSTANCE ABUSE TREATMENT MARKET OVERVIEW

1.1 Product Overview and Scope of Substance Abuse Treatment
1.2 Classification of Substance Abuse Treatment by Types
  1.2.1 Global Substance Abuse Treatment Revenue Comparison by Types (2017-2023)
  1.2.2 Global Substance Abuse Treatment Revenue Market Share by Types in 2017
  1.2.3 Alcohol Abuse Treatment
  1.2.4 Nicotine Abuse Treatment
  1.2.5 Drug Abuse Treatment
1.3 Global Substance Abuse Treatment Market by Application
  1.3.1 Global Substance Abuse Treatment Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Others
1.4 Global Substance Abuse Treatment Market by Regions
  1.4.1 Global Substance Abuse Treatment Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Substance Abuse Treatment Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Substance Abuse Treatment Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Substance Abuse Treatment Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Substance Abuse Treatment Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Substance Abuse Treatment Status and Prospect (2013-2023)
1.5 Global Market Size of Substance Abuse Treatment (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Alkermes
  2.1.1 Business Overview
  2.1.2 Substance Abuse Treatment Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Alkermes Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.2 Allergan
  2.2.1 Business Overview
  2.2.2 Substance Abuse Treatment Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Allergan Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.3 GSK
  2.3.1 Business Overview
  2.3.2 Substance Abuse Treatment Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 GSK Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
  2.4.1 Business Overview
  2.4.2 Substance Abuse Treatment Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Pfizer Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.5 Accord Healthcare
  2.5.1 Business Overview
  2.5.2 Substance Abuse Treatment Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Accord Healthcare Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.6 Amphastar Pharmaceuticals
  2.6.1 Business Overview
  2.6.2 Substance Abuse Treatment Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Amphastar Pharmaceuticals Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.7 Apotex
  2.7.1 Business Overview
  2.7.2 Substance Abuse Treatment Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Apotex Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioCorRx
  2.8.1 Business Overview
  2.8.2 Substance Abuse Treatment Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 BioCorRx Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.9 Cipla
  2.9.1 Business Overview
  2.9.2 Substance Abuse Treatment Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Cipla Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)
2.10 Glenmark
  2.10.1 Business Overview
  2.10.2 Substance Abuse Treatment Type and Applications
    2.10.2.1 Product A
    2.10.2.2 Product B
  2.10.3 Glenmark Substance Abuse Treatment Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL SUBSTANCE ABUSE TREATMENT MARKET COMPETITION, BY PLAYERS

3.1 Global Substance Abuse Treatment Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Substance Abuse Treatment Players Market Share
  3.2.2 Top 10 Substance Abuse Treatment Players Market Share
3.3 Market Competition Trend

4 GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE BY REGIONS

4.1 Global Substance Abuse Treatment Revenue and Market Share by Regions
4.2 North America Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
4.3 Europe Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
4.5 South America Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Substance Abuse Treatment Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA SUBSTANCE ABUSE TREATMENT REVENUE BY COUNTRIES

5.1 North America Substance Abuse Treatment Revenue by Countries (2013-2018)
5.2 USA Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
5.3 Canada Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
5.4 Mexico Substance Abuse Treatment Revenue and Growth Rate (2013-2018)

6 EUROPE SUBSTANCE ABUSE TREATMENT REVENUE BY COUNTRIES

6.1 Europe Substance Abuse Treatment Revenue by Countries (2013-2018)
6.2 Germany Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
6.3 UK Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
6.4 France Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
6.5 Russia Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
6.6 Italy Substance Abuse Treatment Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC SUBSTANCE ABUSE TREATMENT REVENUE BY COUNTRIES

7.1 Asia-Pacific Substance Abuse Treatment Revenue by Countries (2013-2018)
7.2 China Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
7.3 Japan Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
7.4 Korea Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
7.5 India Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Substance Abuse Treatment Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA SUBSTANCE ABUSE TREATMENT REVENUE BY COUNTRIES

8.1 South America Substance Abuse Treatment Revenue by Countries (2013-2018)
8.2 Brazil Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
8.3 Argentina Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
8.4 Colombia Substance Abuse Treatment Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE SUBSTANCE ABUSE TREATMENT BY COUNTRIES

9.1 Middle East and Africa Substance Abuse Treatment Revenue by Countries (2013-2018)
9.2 Saudi Arabia Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
9.3 UAE Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
9.4 Egypt Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
9.5 Nigeria Substance Abuse Treatment Revenue and Growth Rate (2013-2018)
9.6 South Africa Substance Abuse Treatment Revenue and Growth Rate (2013-2018)

10 GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SEGMENT BY TYPE

10.1 Global Substance Abuse Treatment Revenue and Market Share by Type (2013-2018)
10.2 Global Substance Abuse Treatment Market Forecast by Type (2018-2023)
10.3 Alcohol Abuse Treatment Revenue Growth Rate (2013-2023)
10.4 Nicotine Abuse Treatment Revenue Growth Rate (2013-2023)
10.5 Drug Abuse Treatment Revenue Growth Rate (2013-2023)

11 GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SEGMENT BY APPLICATION

11.1 Global Substance Abuse Treatment Revenue Market Share by Application (2013-2018)
11.2 Substance Abuse Treatment Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
11.5 Others Revenue Growth (2013-2018)

12 GLOBAL SUBSTANCE ABUSE TREATMENT MARKET SIZE FORECAST (2018-2023)

12.1 Global Substance Abuse Treatment Market Size Forecast (2018-2023)
12.2 Global Substance Abuse Treatment Market Forecast by Regions (2018-2023)
12.3 North America Substance Abuse Treatment Revenue Market Forecast (2018-2023)
12.4 Europe Substance Abuse Treatment Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Substance Abuse Treatment Revenue Market Forecast (2018-2023)
12.6 South America Substance Abuse Treatment Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Substance Abuse Treatment Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Substance Abuse Treatment Picture
Table Product Specifications of Substance Abuse Treatment
Table Global Substance Abuse Treatment and Revenue (Million USD) Market Split by Product Type
Fi